BNTX institutional ownership changes in Q2 2026: 66 institutions opened or added positions, 63 trimmed or exited. BNTX (BioNTech SE) is held by 131 institutional investors as of Q2 2026. Top institutional shareholders: FMR LLC ($704.6M), PRIMECAP Management Co. ($351M), Dodge & Cox ($342.2M). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Oct 9, 2026 · Activists May 15, 2026 · Congress Sep 12, 2025
Top Holders
Showing 1-20 of 144
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about BNTX
Who owns BNTX?
131 institutional investors held BNTX on June 30, 2026, led by FMR LLC ($704.6M), PRIMECAP Management Co. ($351M) and Dodge & Cox ($342.2M).
How many hedge funds hold BNTX?
131 institutional investors reported BNTX in their 13F filings for the quarter ended June 30, 2026, $3.5B in all. 8 of them are rated Elite.
Are institutions buying or selling BNTX?
Buying, on balance. In Q2 2026, 66 institutions opened or added to positions in BNTX and 63 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer
